OverviewChartNewsTraderScreen

BVT Put 220 BIIB 20.09.2024/  DE000VM3MJC4  /

Frankfurt Zert./VONT
9/3/2024  10:36:37 AM Chg.+0.003 Bid10:52:15 AM Ask10:52:15 AM Underlying Strike price Expiration date Option type
0.141EUR +2.17% 0.142
Bid Size: 94,000		 0.168
Ask Size: 94,000		 Biogen Inc 220.00 USD 9/20/2024 Put
GlobeNewswire 8/26 Long Term Investor News: Biogen, Seritage Growth, Arbor Realty, and Five Below Investors are Encoura...
GlobeNewswire 8/26 MDA Kicks Off Muscular Dystrophy Awareness Month in September with ‘30 Days of Strength’ Campaign wi...
GlobeNewswire 8/19 Tiziana Life Sciences Appoints New Chief Executive Officer
GlobeNewswire 8/19 Fulcrum Therapeutics Strengthens Leadership Team with the Appointments of Isabel Kalofonos as Chief ...
GlobeNewswire 8/15 Soleno Therapeutics Announces Updates to its Board of Directors
GlobeNewswire 8/15 Abata Therapeutics Announces Strategic Investment from Bristol Myers Squibb Supporting Advancement o...
GlobeNewswire 8/8 Royalty Pharma Reports Second Quarter 2024 Results
GlobeNewswire 8/1 C4 Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
TeleTrader 8/1 Biogen books $2.5 billion in Q2 revenue
GlobeNewswire 8/1 Denali Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
GlobeNewswire 7/31 Vaccinex Reports Positive Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease
GlobeNewswire 7/30 New Clinical Data Demonstrates Three Years of Continuous Treatment with Dual-Acting LEQEMBI® (lecane...
GlobeNewswire 7/30 Montara Therapeutics Closes $8 Million Seed Round Led by SV Health Investors’ Dementia Discovery Fun...
GlobeNewswire 7/30 Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Path...
GlobeNewswire 7/26 CVS Health Corporation Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law...
GlobeNewswire 7/26 Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union
GlobeNewswire 7/26 BIOGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Biogen Inc. on Behalf of Long-Term Stockh...
GlobeNewswire 7/22 Lost Money on Biogen Inc.(BIIB)? Join Class Action Suit Seeking Recovery – Contact The Gross Law Fir...
GlobeNewswire 7/22 DEADLINE ALERT for CMBM, BIIB, DRCT, and FSLY: The Law Offices of Frank R. Cruz Reminds Investors of...
GlobeNewswire 7/20 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen...
GlobeNewswire 7/20 BIIB DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Biogen Inc. (BIIB) Se...
GlobeNewswire 7/19 MONDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors wit...
GlobeNewswire 7/18 DEADLINE ALERT for CMBM, BIIB, DRCT, FSLY: Law Offices of Howard G. Smith Reminds Investors of Class...
GlobeNewswire 7/18 SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen
GlobeNewswire 7/18 BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Sub...